About Stata DX

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies. The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about th

Top 100 in Chemical
Top 100 in Chemical in United States
Company Highlights
Year Founded

2022

icon-altEmployees

8

Location (HQ)

USA

Since Last Funding

6 months

Monthly Website Visitors

1.1K

icon-altTotal Investment Amt

$3.2M

Last Funding Round

Series A

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Medical Device

Medical Equipment Manufacturing

Chemical Engineering